The role of continuous glycose monitoring in compensation of type 1 diabetes mellitus in children
Year: 2022, volume 18 Issue: №4 Pages: 576-580
Heading: Pediatrics Article type: Original article
Authors: Bolotova N.V., Filina N.Yu., Polyakov V.K., Shagirov A.A., Companietz O.V., Timofeeva S.V.
Organization: Saratov State Medical University
Heading: Pediatrics Article type: Original article
Authors: Bolotova N.V., Filina N.Yu., Polyakov V.K., Shagirov A.A., Companietz O.V., Timofeeva S.V.
Organization: Saratov State Medical University
Summary:
Abstract. Objective: to determine the role of continuous glucose monitoring in achieving compensation in children with type 1 diabetes mellitus with different levels of glycemic control. Material and methods. The evaluation of clinical and metabolic parameters in 80 adolescents with diabetes mellitus with varying degrees of carbohydrate metabolism compensation was carried out. Based on the Flash monitoring data, insulin dosages were corrected, after which the monitoring results were compared before and after the adjustment of insulin therapy. Results. As a result of the correction of insulin therapy in children with HbAc 9% or more, according to monitoring data, the time spent by glycemia in the target range increased. There was no significant increase in the number of hypoglycemia. In patients with HbAc less than 9%, after changing therapy, the number of children with glycemia in the target range significantly increased, and the number of hypoglycemia decreased. The variability of daily glycemia significantly improved (p=0,039). Conclusion. The use of the Flash Glucose Monitoring System in patients with type 1 diabetes mellitus made it possible to detail glycemic disorders during the day and to conduct an objective control of the correction of insulin therapy according to its indicators.
Bibliography:
1. Dedov II, Shestakova MV, Mayorov AYu. Algorithms of specialized medical care for patients with diabetes mellitus. 10th issue. Moscow: UP PRINT, 2021.
2. DCCT Research Group (Diabetes Control and Complications Trial Research Group). Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr. 1994; (125): 177-88.
3. Nathan DM, Zinman B, Cleary PA, et al. Modernday clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med. 2009; (169): 1307-16.
4. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohe-moglobin. Clinical Chemistry. 2001; (47): 153-63.
5. Gitel EP, Gindis AA, Panin VV. Actual aspects of determination and interpretation of the results of the study of glycated hemoglobin. Clinical Laboratory Diagnostics. 2019; (8): 452-8.
6. Li SH, Harro D, Alfsen J. Effect of diabetes mellitus on sickle hemoglobin quantitation in sickle cell trait. Am J Clin Pathol. 2018; 150(2): 105-5.
7. Lutsenko LA. The role of glycated hemoglobin in the diagnosis and monitoring of diabetes mellitus. Kidneys. 2014; 4 (10): 7-11.
8. Garg S, Zisser Н, Schwartz S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006: (29): 44-50.
9. Thomas D, Revital N, Tadej B, et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017; 40 (12): 1631-40.
10. Demidova TYu, Ushanova FO. Modern technologies of continuous monitoring of glycemia: developing possibilities of control and management. Russian Medical Journal. 2018; 11 (II): 86-90.
11. Davis Т, Salahi A, Welsh JB. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications Diabetes Obes Metab. 2015; 17(12): 1126-32.
12. Campbell FM, Murphy NP, Stewart C, et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr. Diabetes. 2018; 19(7): 1294-1301.
13. Messaaoui A, Tenoutasse S, Crenier L. Flash glucose monitoring accepted in daily life of children and adolescents with type 1 diabetes and reduction of severe hypoglycemia in real-life use. Diabetes Technol Ther. 2019; 21 (6): 329-35.
14. Peterkova VA, Ametov AS, Mayorov AYu, et al. Resolution of the Scientific Advisory Council "Application of continuous glucose monitoring technology with periodic scanning to achieve glycemic control". Diabetes Mellitus. 2021; 24 (2): 185-92.
15. Lopatina LA, Seryozhenko NP, Sokolov DA. Anthropo-metric characteristics of young men according to the classification of J. Tanner. I. P. Pavlov Russian Medical Biological Herald. 2014; (1): 141-7.
16. Antsiferov MB, Demidov NA, Koteshkova ОМ, et al. Assessment of the variability of the glycemic level based on self-control. Results of the pilot project. Endocrinology: News, Opinions, Training. 2021; 10 (2): 26-31.
17. Peterkova VA, ed. Diabetes mellitus in children and adolescents: ISPAD Consensus on Clinical Practice: 2014. Moscow: GEOTAR-Media, 2016; 656 p.
18. Klimontov VV, Mayakina NE. Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications. Diabetes Mellitus. 2014; 17 (2):76-82.
19. Vergier J, Samper М, Dalla-Vale F, et al. Evaluation of flash glucose monitoring after long-term use: A pediatric survey. Prim Care Diabetes. 2019; 13 (1): 63-70.
20. Deeb A, Yousef H, Qahtani NA, et al. Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metab Disord. 2019; 18 (1): 1 -6.
| Attachment | Size |
|---|---|
| 2022_4_576-580.pdf | 332.81 KB |
Русский
English